RECRUITING

The Movie Theater Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Increasing attention has been paid to meals with unusual characteristics that are consumed on a semi-regular basis (e.g., "tailgating," pizza buffets). The purpose of this study is to describe the acute cardiometabolic effects of a cinema-style meal rich in refined sugar, total carbohydrate, and moderate in fat (i.e., soda, popcorn, candy).

Official Title

The Movie Theater Study: Acute Cardiometabolic Effects of a Cinema-Style Meal

Quick Facts

Study Start:2024-03-24
Study Completion:2025-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06444984

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18-45 years old
  2. * Not pregnant or expecting to become pregnant (females only)
  3. * Not postmenopausal (females only).
  4. * Not been diagnosed with a cardiometabolic conditions (e.g., heart disease, type 2 diabetes)
  5. * Not been diagnosed with a chronic inflammatory condition (e.g., rheumatoid arthritis, inflammatory bowel disease).
  6. * Does not regularly take anti-inflammatory drugs (more than 2x week) or able to temporarily suspend use of anti-inflammatory drugs.
  7. * Does not use glucose-lowering drugs (e.g., metformin)
  8. * Does not use lipid-lowering drugs (e.g., statins)
  9. * Does not use tobacco products or any illicit drugs.
  10. * Does not have a pacemaker.
  1. * Not 18-45 years old
  2. * Pregnant or expecting to become pregnant (females only)
  3. * Postmenopausal (females only).
  4. * Been diagnosed with a cardiometabolic conditions (e.g., heart disease, type 2 diabetes)
  5. * Been diagnosed with a chronic inflammatory condition (e.g., rheumatoid arthritis, inflammatory bowel disease).
  6. * Regularly take anti-inflammatory drugs (more than 2x week) or unable to temporarily suspend use of anti-inflammatory drugs.
  7. * Use glucose-lowering drugs (e.g., metformin)
  8. * Use lipid-lowering drugs (e.g., statins)
  9. * Use tobacco products or any illicit drugs.
  10. * Has a pacemaker.

Contacts and Locations

Study Contact

Bryant Keirns, PhD
CONTACT
7652858356
bryant.keirns@bsu.edu

Principal Investigator

Bryant Keirns
PRINCIPAL_INVESTIGATOR
Ball State University

Study Locations (Sites)

Health Professions Building, Ball State University
Muncie, Indiana, 47306
United States

Collaborators and Investigators

Sponsor: Ball State University

  • Bryant Keirns, PRINCIPAL_INVESTIGATOR, Ball State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-24
Study Completion Date2025-03

Study Record Updates

Study Start Date2024-03-24
Study Completion Date2025-03

Terms related to this study

Additional Relevant MeSH Terms

  • Hyperglycemia, Postprandial
  • Hyperinsulinemia